Results 51 to 60 of about 14,759,288 (215)

Six‐week postoperative opioid use and pain following a randomized controlled trial evaluating multimodal analgesia for head and neck free flap patients

Laryngoscope Investigative Otolaryngology
Introduction Head and neck malignancy treatment often involves invasive surgeries, necessitating effective postoperative pain control. However, chronic reliance on opioid medications remains a challenge for many patients after surgery.
Sarah F. Wagoner, Amelia S. Lawrence, Rahul Alapati, Bryan Renslo, Chelsea S. Hamill, Antonio Bon Nieves, Maraya Baumanis, Andrés M. Bur, Kiran Kakarala, Kevin J. Sykes, Yelizaveta Shnayder   +10 more
doaj   +1 more source

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review

Substance Abuse Treatment, Prevention, and Policy, 2023
Background The COVID-19 pandemic led to an unprecedented relaxation of restrictions on take-home doses in opioid agonist treatment (OAT). We conducted a mixed methods systematic review to explore the impact of these changes on program effectiveness and ...
Alison Adams, Sarin Blawatt, Tianna Magel, Scott MacDonald, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter, Eugenia Oviedo-Joekes   +8 more
doaj   +1 more source

Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: a 22 year data linkage study [PDF]

, 2014
Foreword: Prisoners experience high rates of drug dependence, health problems and premature mortality. Without intervention, they often come into further contact with the criminal justice system, creating further health risk.
Natasa Gisev, Weatherburn, Don J., Burns, L., Lucy Burns, Louisa Degenhardt, Degenhardt, L., Gisev, Natasha, Mattick, R., Tony Butler, Weatherburn, Don, Kimber, J., Don Weatherburn, Kimber, Jo, Degenhardt, Louisa, Amy Gibson, Gisev, N., Larney, S ; https://orcid.org/, Gibson, Amy (R17420), Burns, Lucy, Larney, Sarah, Richard Mattick, Butler, Tony, Weatherburn, D., Dobbins, Tim, Gisev, N ; https://orcid.org/, Degenhardt, L ; https://orcid.org/, Tim Dobbins, Gibson, Amy, Weatherburn, D, Gibson, A., Mattick, RP, Larney, S., Gisev, Natasa, Jo Kimber, Dobbins, T ; https://orcid.org/, Mattick, Richard P., Dobbins, T., Sarah Larney, Kimber, J, Burns, L ; https://orcid.org/, Gibson, A ; https://orcid.org/, Butler, T ; https://orcid.org/, Dobbins, Timothy A., Mattick, Richard   +43 more
core   +1 more source

Bridging the Gap Between Knowledge and Practices Pertaining to Naloxone Use: A Single-Institution Experience in North Carolina

Journal of Patient-Centered Research and Reviews
Naloxone is a life-saving medication for opioid overdose, which claims many lives annually. This study investigated provider attitudes about, beliefs about, and barriers to naloxone use to inform an increase in provider prescription of naloxone.
Michael S. Argenyi, Gisele Bailey, Christopher J. McLouth, Erin Barnes, Candice J. McNeil   +4 more
doaj   +1 more source

The Role of Onabotulinum Toxin Type A in the Management of Chronic Non-migraine Headaches

Frontiers in Neurology, 2019
Objectives: FDA has approved Onabotulinum toxin type A (BoNTA) for prophylactic treatment of chronic migraines. Recent studies have explored its potential new indications, like treating post-traumatic headaches.Patients and Methods: This is a ...
Cassie Jia, Scott Lucchese, Fang Zhang, Raghav Govindarajan   +3 more
doaj   +1 more source

National opioid pharmacotherapy statistics 2014 [PDF]

, 2015
Summary Dependence on opioid drugs is associated with a range of health and social problems that affect individual drug users, their family and friends, and the wider public.
Australian Institute of Health and Welfare
core  

Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates

, 2015
Joseph A Boscarino,1 Stuart N Hoffman,1 John J Han2 1Center for Health Research, 2Department of Pain Medicine, Geisinger Clinic, Danville, PA, USAAims: Previously, we estimated the prevalence and risk factors for prescription opioid-use disorder among ...
John Han, Joseph Boscarino, Stuart Hoffman, Hoffman SN, Boscarino JA, Han JJ   +5 more
core   +1 more source

Editorial: Opioids and opioid-use disorders

Frontiers in Pharmacology, 2023
Giordano de Guglielmo, Marsida Kallupi, Andrea Cippitelli, Daniele Caprioli, Daniele Caprioli, Kabirullah Lutfy   +5 more
openaire   +4 more sources

UNODC Integrated strategy on the global opioid crisis. [PDF]

, 2018
Recent years have seen a sharp rise globally in opioid overdose deaths. Currently, the majority of the world burden of disease caused by drug use disorders is attributable to opioid use.

core  

Practice guidelines for the administration of buprenorphine for treating opioid use disorder.

, 2021
The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder provides eligible US physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, and ...

core